MARATTO

article · Environmental Science and Pollution Research

Design and application of a TiO2/clay/Ag hybrid nanocomposite for environmental remediation of cytotoxic pharmaceuticals

2026Open accessUniversity of Gabès

Abstract

The contamination of water by cytostatic drugs poses a significant ecological risk. This study presents a novel TiO<sub>2</sub>/clay/Ag catalyst, synthesized through a simplified sol-gel method, and applied for the efficient removal of etoposide (ETP) from aqueous environments. A thorough characterization of the catalyst's structural and morphological properties was carried out using various analytical techniques (XRD, FTIR, SEM, EDX, XPS). Several parameters, such as contact time, photocatalyst dosage, pH, and drug concentration, were studied. Under visible light irradiation, complete degradation (100%) of ETP molecules was achieved within 30 min. The degradation process followed pseudo-first-order kinetics. The catalyst's remarkable reusability is another key strength, as it showed excellent performance over five consecutive cycles, confirming its long-term applicability. In addition to its environmental sustainability and economic feasibility, this material demonstrated exceptional performance when applied to real environmental samples (surface water, incoming and outgoing wastewater). These findings suggest the catalyst's potential as a powerful, eco-friendly, and scalable approach to reducing pharmaceutical contamination in water.

Research topics

  • Pharmaceutical and Antibiotic Environmental Impacts
  • TiO2 Photocatalysis and Solar Cells
  • Advanced Photocatalysis Techniques

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s11356-026-37498-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.